BLCO Bausch & Lomb Corp Insider Trading

CEO Brent L. Saunders bought 14,700 shares of BLCO at $17.14 (2026-03-06); 5 other insiders also bought within 14 days

CEO and Chairman Brent L. Saunders purchased 14,700 shares at $17.14, increasing his holdings by 1.5% to 981,275 shares. This transaction is part of a cluster pattern, with 5 other insiders also buying BLCO within the past 14 days. At the company level, context is mixed: Bausch & Lomb reported $1.3B in latest quarterly revenue (+6.5% annual growth) but net income of $-28.0M, indicating the company was unprofitable over its most recent full fiscal year. Saunders' own track record at BLCO is noteworthy—his 2 prior purchases at this ticker returned +4.0% and +4.1% at 30 days and +29.0% and +31.0% at 90 days respectively. The current share price of $17.12 is 8.0% below the 52-week high of $18.60, positioning this buy near the upper range of recent trading.

EVP & Chief Legal Officer buys 14,600 BLCO shares at $17.15; 5 other insiders bought within 14 days as company reports $-28.0M net loss.

Bailey A Robert D, EVP & Chief Legal Officer, purchased 14,600 shares at $17.15 on 2026-03-06, increasing his holdings by 6.3% to 246,490 shares total. This transaction is part of a cluster pattern with 5 other insiders also buying within the past 14 days, indicating coordinated insider accumulation. The buy occurs against an unfavorable fundamental backdrop: the company reported $-28.0M net income on $1,281,000,000 revenue in the latest quarter and was unprofitable over its most recent full fiscal year, despite annual revenue growth of +6.5%. The concurrent multi-insider purchasing activity during a period of negative earnings suggests attention to valuation opportunity, though the cluster pattern itself requires scrutiny given the underlying profitability pressures.

CFO Sam Eldessouky buys 4,000 BLCO shares at $17.13; cluster pattern shows 5 other insiders buying in 14 days

Eldessouky Sam, EVP and CFO, purchased 4,000 shares at $17.13, bringing his total holdings to 407,130 shares—a modest 1.0% increase in position size. The transaction is noteworthy because it is part of a cluster buy pattern: 5 other insiders also purchased shares within the past 14 days. While Bausch & Lomb reported $1,281,000,000 in latest quarterly revenue and 6.5% annual revenue growth, the company remains unprofitable with $-28,000,000 in net income for its most recent full fiscal year. The concurrent buying activity by multiple insiders at current prices ($17.12, near the 52-week high of $18.60) merits attention as a potential signal of leadership's directional view, though it occurs during a period of negative earnings.

Director Ross Thomas W. Sr. buys 4,500 shares of BLCO at $17.68; 5 other insiders bought within 14 days

Ross Thomas W. Sr., a director of Bausch & Lomb, purchased 4,500 shares at $17.68 on 2026-03-03, increasing his holdings by 6.9% to 69,391 shares. This transaction is notable because it coincides with a broader insider buying cluster: 5 other insiders also purchased shares within the past 14 days. The company's recent fundamentals show mixed signals—Revenue of $1,281,000,000.00 in the latest quarter reflects 6.5% annual growth, but the company reported Net income of $-28,000,000.00 and remains unprofitable on a full-year basis. The stock is currently trading at $18.05, up 7.6% over 30 days and 7.4% over 90 days, but sits 3.0% below its 52-week high of $18.60. Multiple insiders buying concurrently in an otherwise unprofitable company warrants attention to understand the underlying rationale.

Director Alfonso Eduardo bought 4,300 shares of BLCO at $17.90 on 2026-03-02; cluster of 5 other insiders also bought within 14 days

Director Alfonso Eduardo purchased 4,300 shares at $17.90, increasing his holdings by 45.0% to 13,855 shares post-transaction. This purchase occurs as part of a broader pattern: 5 other insiders also bought within the past 14 days, signaling coordinated insider accumulation at the company. The timing is notable given that BLCO is unprofitable (net income was $-28,000,000.00 for its most recent full fiscal year) despite posting annual revenue growth of +6.5% to $1,281,000,000.00, suggesting insiders may be acquiring shares during a period of operational challenges. Current price of $17.98 sits -3.3% from the 52-week high of $18.60, placing the transaction near recent highs within a volatile trading range of $10.90–$18.60.

Director Andrew Von Eschenbach buys 4.4K shares of BLCO at $18.30; 5 other insiders bought in past 14 days amid unprofitable operations.

Von Eschenbach purchased 4,364 shares at $18.30, increasing his holding from 66,450 to 70,814 shares (+6.6%). This transaction occurs within a cluster pattern: 5 other insiders also bought within the past 14 days, suggesting coordinated directional conviction among the board and management. The company carries a $-28.0M net loss despite $1.3B quarterly revenue and 6.5% annual growth, indicating operational challenges beneath the revenue line. The stock currently sits $17.98, -3.3% below its 52-week high, while posting 30-day gains of +7.7%. Von Eschenbach's prior trade at BLCO (May 2025) achieved a 90-day return of +16.0%, consistent with his cross-ticker track record's 100% win rate over 90 days. The cluster activity combined with his historical execution suggests alignment with near-term price momentum, though profitability remains a material concern for valuation sustainability.

Director Collis Steven H buys 15,000 shares of BLCO at $17.81; holdings increase 153.9%. 2 other insiders also bought in past 14 days.

Director Collis Steven H purchased 15,000 shares at $17.81 on 2026-02-23, raising his holdings from 9,746 to 24,746 shares—a 153.9% increase in position size. The stock is at $18.44, near its 52-week high of $18.44, after gaining +13.8% over the past 90 days. Alongside this buy, 2 other insiders purchased shares within the past 14 days, forming a cluster acquisition pattern. BLCO is unprofitable (latest quarter net income: $-28.0M), though revenue grew +6.5% year-over-year to $1,281,000,000.00. The coincident buying by multiple insiders during near-peak valuations—coupled with the company's current unprofitability—warrants observation of whether this reflects conviction in a recovery path or responds to other considerations.

Director Robertson bought 4,400 shares of BLCO at $17.90 on 2026-02-20; cluster pattern with 2 other insider purchases in 14 days

Director Russell C Robertson purchased 4,400 shares at $17.90, increasing his holdings to 76,807 shares (+6.1% vs pre-transaction holdings), as part of a cluster of 3 insider buys within 14 days. The transaction occurred near the 52-week high of $18.44, with the stock up 8.6% over 30 days and 13.8% over 90 days. However, context matters: Bausch & Lomb reported negative net income of $-28,000,000.00 in its most recent full fiscal year despite generating $1,281,000,000.00 in quarterly revenue with +6.5% annual growth. Multiple directors accumulating shares simultaneously in an unprofitable company warrants investor scrutiny of the rationale underlying this coordinated buying activity.

Director Ling Karen bought 4,000 shares of BLCO at $17.74 (Feb 2026); cluster buy signal with 2 other insiders in 14 days

Director Ling Karen purchased 4,000 shares at $17.74 on 2026-02-19, increasing her holdings to 45.7K shares, representing a 9.6% increase in her position. The transaction is part of a cluster pattern: 2 other insiders also bought within the past 14 days. While BLCO is currently near its 52-week high of $17.99 and has gained 13.2% over 90 days, the company remains unprofitable with full-year net income of $-28.0M despite quarterly revenue of $1.3B and 6.5% annual revenue growth. The synchronized buying activity among multiple insiders warrants attention, though the company's persistent losses present a material countervailing factor for equity investors.

BLCO CEO Brent Saunders buys 22,000 shares at $11.28; stock now at $11.80 amid company losses

Brent L Saunders, CEO and Chairman, purchased 22,000 shares at $11.28 on 2025-05-22, increasing his holdings by +3.1% to 741.2K shares. The purchase occurs against a backdrop of material headwinds: Bausch & Lomb posted a net loss of $-212.0M in its latest quarter despite $1.1B in revenue, and the stock is trading -43.6% from its 52-week high of $20.93. Saunders' cross-ticker track record shows a 66.67% 90-day win rate on buys (avg 90d return -9.9%), and his prior BLCO buy on 2024-08-05 generated a +31.0% 90-day return—indicating his picks at this company have outperformed his broader pattern. The current purchase at $11.28 is below the 52-week low of $10.90 adjusted for timing, placing it in a depressed zone relative to recent history, though the company's unprofitability leaves material downside risk unresolved.